Jason Varney Photography
In a year in which several Big Pharma players felt pain as the Vioxx imbroglio settled out – take August's $253 million settlement against Merck, for example – news in funding, policy, and strategy, from government agencies to biotechs, suggests that the industry is still as robust as ever. Here's our unofficial Top 10 list of developments, in no particular order.
© Alex Wong/Getty Images
Keep it under your hat, but this guy Bill Gates may be onto something. In 2005, the Bill and Melinda Gates Foundation made announcements about two immense groups of international grants for health-related research and treatment: $258.3 million for malaria, and $436 million for challenges in global health. That's just a fraction of the $5.5 billion in such grants the foundation has made since its inception.
The foundation isn't the only one increasing its funding of research in the United States; research ...
